Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",21330,189,0.97 [0.74-1.27],0.8042138391111947
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",22508,239,1.06 [0.84-1.34],0.6091577567426681
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22231,1714,1.11 [1.02-1.21],0.0189131174221895
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Candidiasis,22515,533,1.09 [0.93-1.27],0.2840903058080309
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21766,4121,1.11 [1.05-1.17],0.0002288842272507
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21725,4220,1.09 [1.03-1.15],0.0027484192432422
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,22235,1399,1.11 [1.01-1.22],0.0301638225651032
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,22422,124,1.07 [0.78-1.48],0.6790360348982913
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,19740,1262,1.15 [1.04-1.27],0.008289006373905
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19072,1554,1.15 [1.05-1.26],0.0030294022269927
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,18561,330,1.20 [0.98-1.45],0.0716933525149832
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,14659,2690,1.08 [1.01-1.16],0.024965390107239
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,18507,483,1.24 [1.06-1.46],0.0079258225023964
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22489,1653,1.11 [1.01-1.21],0.0220490647369114
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Mycoses,22603,621,1.10 [0.95-1.27],0.1900369399698114
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,21734,1217,1.09 [0.98-1.21],0.099805934407665
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22532,1391,1.11 [1.01-1.23],0.0264531728290663
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,21075,239,1.07 [0.85-1.35],0.5716044547058989
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,22662,66,1.56 [1.06-2.29],0.0225362180766565
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22358,1217,1.14 [1.03-1.26],0.014028739541478
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,22374,76,1.39 [0.95-2.03],0.0927108209826851
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other viral diseases,22598,136,1.48 [1.12-1.96],0.0053637557248421
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",22577,115,1.47 [1.08-1.99],0.0136260288192662
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,21007,490,1.19 [1.02-1.40],0.0294942401774657
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,20817,300,1.06 [0.86-1.31],0.5763514790655802
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,20968,132,1.52 [1.15-2.01],0.0034706884113405
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,22647,46,0.96 [0.56-1.67],0.8923650355994781
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,22597,165,1.03 [0.77-1.36],0.8587744421182968
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral warts,22486,54,1.49 [0.97-2.29],0.0701553074424338
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],22504,72,0.81 [0.51-1.27],0.3511454399042456
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm,22374,259,0.75 [0.59-0.96],0.0215471570969051
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,22579,39,0.66 [0.35-1.24],0.1983488144697983
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,22564,43,0.93 [0.53-1.65],0.8089217426714511
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10805,83,0.80 [0.52-1.21],0.2899625489892655
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22205,1628,1.02 [0.93-1.12],0.6669543744125622
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of meninges,22647,65,1.52 [1.03-2.25],0.0343893481312914
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,22571,77,1.22 [0.82-1.81],0.3203774998719491
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,22634,115,0.94 [0.66-1.33],0.7218140804086861
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of ovary,11789,73,0.83 [0.53-1.28],0.3910260157367515
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Ascending colon,22622,428,0.98 [0.82-1.17],0.7969318961444147
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Caecum,22628,382,0.99 [0.82-1.20],0.9443707803305256
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",22515,82,0.83 [0.54-1.27],0.3914489557888696
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Descending colon,22620,248,1.00 [0.79-1.26],0.9770798852867484
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Rectum,22581,394,0.98 [0.81-1.18],0.8361195924735564
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,22511,658,1.05 [0.91-1.21],0.4796558203070598
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Transverse colon,22606,528,0.97 [0.82-1.14],0.6833570183021289
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Carcinoma in situ of breast,8869,47,0.62 [0.35-1.11],0.1082325953019895
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",8912,64,1.18 [0.77-1.82],0.4511821999282527
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",16187,69,2.82 [2.17-3.67],1.0603776117299476e-14
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",16215,97,1.46 [1.04-2.05],0.0298549813193632
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",22605,121,0.91 [0.65-1.28],0.5837015859813189
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma, any site",22606,119,0.91 [0.65-1.28],0.5930662215015567
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Leiomyoma of uterus,11526,160,0.95 [0.71-1.28],0.7543778014222657
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Lung cancer and mesothelioma,14342,471,1.06 [0.90-1.26],0.4775332844870058
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Lymphoid leukaemia,16189,71,2.80 [2.16-3.63],8.092189256487903e-15
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",16339,221,1.19 [0.94-1.51],0.156219534344234
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",16426,308,0.97 [0.78-1.20],0.7710702417299928
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",8987,101,1.01 [0.70-1.45],0.9496179715823766
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",16222,104,1.13 [0.79-1.62],0.4877280435715128
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",16261,143,1.15 [0.85-1.56],0.3653084870661945
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",16237,119,1.14 [0.81-1.59],0.45611924638004
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",8972,86,0.92 [0.62-1.37],0.6820677357369609
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",16242,124,0.95 [0.68-1.33],0.7528017929167985
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",8180,948,1.04 [0.92-1.17],0.5653878021354314
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",16250,132,0.76 [0.54-1.06],0.1095236596180548
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",16206,88,1.39 [0.96-2.01],0.0832291783559309
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,16261,143,1.13 [0.83-1.53],0.4416780375699051
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi,22521,181,1.24 [0.96-1.59],0.1035489996105599
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi of trunk,22635,76,1.60 [1.13-2.27],0.0087703129402406
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanoma in situ,16170,109,1.09 [0.77-1.54],0.6248493126851413
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",16236,118,1.42 [1.04-1.94],0.02821242648912
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",16314,196,1.58 [1.26-1.99],9.008389087408964e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",16439,321,0.88 [0.71-1.09],0.2437921140304062
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",16241,123,1.62 [1.22-2.17],0.0010190625958253
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Other benign neoplasms of skin,22488,158,1.05 [0.79-1.40],0.7380942025429675
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",17568,1450,1.02 [0.92-1.12],0.7551414376676021
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",17651,1533,1.03 [0.94-1.13],0.5304252562824013
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,22368,381,1.27 [1.07-1.52],0.0071291275931179
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,20383,161,1.35 [1.03-1.76],0.030053084045497
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22054,67,1.64 [1.12-2.39],0.0107542993680305
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21912,3423,1.13 [1.06-1.20],0.0001338684862266
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,20975,72,1.04 [0.68-1.59],0.8673772954222059
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,22196,64,1.26 [0.82-1.94],0.2907266228317611
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22155,1933,1.10 [1.01-1.19],0.0289592519804265
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22154,1932,1.09 [1.01-1.19],0.0309810848827016
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,20333,111,1.12 [0.80-1.57],0.521047545748081
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22308,1405,1.22 [1.11-1.34],2.883043268689129e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,22243,111,0.99 [0.70-1.40],0.9588973735160342
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22057,70,1.02 [0.66-1.58],0.9352854391701372
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22060,73,1.35 [0.91-2.00],0.136751028134837
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,22483,351,0.98 [0.80-1.19],0.8053346577351594
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,22534,38,1.08 [0.60-1.93],0.7949182132365623
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",22420,288,0.82 [0.65-1.03],0.0816073476821839
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,21033,130,0.94 [0.68-1.30],0.7058340233271541
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,15140,408,1.13 [0.94-1.35],0.1979410188106596
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21187,97,0.99 [0.64-1.54],0.9758293141260675
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21198,108,1.05 [0.75-1.48],0.783356221645184
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14802,70,1.26 [0.83-1.91],0.2773092547342385
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21052,63,0.86 [0.53-1.39],0.5463057853937557
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,20286,313,0.91 [0.74-1.13],0.3954624451362064
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",21875,950,1.00 [0.88-1.12],0.938908533488652
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,21403,478,0.99 [0.84-1.18],0.9442829610737088
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,21143,218,1.17 [0.92-1.48],0.204234353783683
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,22380,1391,1.14 [1.03-1.25],0.0081498131966539
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,19051,1347,1.14 [1.04-1.26],0.0068802958931647
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14823,91,0.92 [0.62-1.37],0.6909561286579153
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20409,97,1.15 [0.80-1.64],0.4510556907052022
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,15093,361,1.11 [0.92-1.34],0.2884600167023052
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14785,53,1.04 [0.63-1.71],0.8829178225248838
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19244,4512,1.05 [1.00-1.11],0.0583410717721626
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,14988,256,1.01 [0.81-1.28],0.9026338693621528
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,15427,695,1.07 [0.93-1.23],0.3184916006996612
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,22601,359,1.14 [0.95-1.38],0.1643868439115222
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,22395,153,1.16 [0.87-1.55],0.2997552699443101
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,14884,152,1.14 [0.85-1.52],0.3870136356514728
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14809,77,1.32 [0.89-1.94],0.1635849808515632
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22034,1722,1.04 [0.95-1.13],0.3862166770308189
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,15111,379,1.18 [0.98-1.42],0.0878127288498093
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,15150,418,1.17 [0.98-1.39],0.0881836175899608
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15581,849,1.15 [1.01-1.30],0.030852815503426
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14907,175,0.97 [0.73-1.29],0.8337660342531883
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,22386,144,1.15 [0.85-1.54],0.3614177486685315
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,15618,886,1.02 [0.90-1.15],0.7672136815822237
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,15377,645,1.07 [0.93-1.24],0.3335916752067495
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,20053,80,1.14 [0.77-1.69],0.5041116376004484
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,21037,6305,1.06 [1.01-1.11],0.0186962071120665
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20371,59,1.02 [0.64-1.64],0.9289263602407688
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20363,51,0.80 [0.47-1.37],0.4212207166539841
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22480,1866,0.94 [0.86-1.03],0.1610230989337427
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22477,1863,0.94 [0.86-1.03],0.1622749462101038
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20377,65,0.99 [0.63-1.55],0.9508980877014492
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,22318,1110,1.06 [0.95-1.18],0.3179273288802072
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",16937,2205,1.07 [0.99-1.16],0.0784494791094047
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,22646,306,1.04 [0.84-1.28],0.7053312764418845
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,21052,127,1.38 [1.03-1.86],0.0325021306880372
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21322,114,0.98 [0.69-1.38],0.902333330395816
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21365,157,1.32 [1.01-1.73],0.0424600234284036
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14928,196,1.18 [0.92-1.52],0.1898288679544874
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,19925,179,0.97 [0.74-1.28],0.8291020374020248
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2418,95,1.04 [0.71-1.53],0.8303397999304426
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2583,300,0.93 [0.75-1.16],0.5212938757500025
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,19826,80,1.43 [1.02-2.01],0.0377341939454063
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2394,74,1.02 [0.66-1.58],0.9206692908593344
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21834,2088,1.12 [1.03-1.21],0.0063558891647555
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,21551,626,0.90 [0.78-1.05],0.1852392941380126
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,20410,437,1.10 [0.92-1.30],0.2944346830101572
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15827,1095,1.09 [0.98-1.22],0.120633541899448
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",22526,301,1.03 [0.84-1.27],0.7590112299305349
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),21208,266,0.81 [0.64-1.02],0.0751870587911647
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Angina pectoris,19556,1541,1.08 [0.98-1.18],0.1064385174614402
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Aortic aneurysm,21311,369,0.85 [0.70-1.04],0.1136912922409788
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,21027,85,1.38 [0.96-1.98],0.0786461849189261
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",21228,286,1.30 [1.07-1.59],0.0096297793444124
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11465,2773,0.98 [0.92-1.05],0.6035831801344614
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,AV-block,17206,653,1.10 [0.96-1.27],0.1688940324798026
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",22578,569,0.93 [0.80-1.09],0.3965997668875169
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiac arrest,8953,261,1.25 [1.01-1.56],0.0401905215023523
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiomyopathy,16747,194,0.86 [0.66-1.13],0.2849597796622958
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",16658,105,0.91 [0.63-1.32],0.6190805877230978
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,22657,80,1.48 [1.03-2.14],0.0363568897261636
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Conduction disorders,18062,1509,1.02 [0.93-1.12],0.6587516983172814
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20699,2707,1.06 [0.99-1.14],0.0770269004354757
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18173,8702,1.03 [0.99-1.07],0.1033802843997461
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,DVT of lower extremities,21127,331,1.04 [0.86-1.27],0.6761719941255688
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Endocarditis,16655,102,1.12 [0.79-1.60],0.5298389331858979
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22375,1633,1.07 [0.97-1.17],0.1611709603837711
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertension,19386,7755,1.05 [1.01-1.09],0.0250695734682313
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19404,7773,1.05 [1.01-1.09],0.02367571867557
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, portal",22496,89,0.71 [0.47-1.08],0.1084908191726567
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",11884,253,1.14 [0.91-1.43],0.2521821025917934
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,11836,205,1.34 [1.06-1.69],0.0150324288934575
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypotension,22479,1607,1.06 [0.97-1.16],0.1991994665295033
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,21389,148,0.92 [0.68-1.25],0.5945443994556756
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20868,2853,1.06 [0.99-1.13],0.090645592690431
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22153,781,1.09 [0.95-1.23],0.2118805849864374
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Left bundle-branch block,17065,512,1.08 [0.92-1.26],0.3753266296586963
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,21982,1041,1.07 [0.96-1.19],0.249190955117153
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",18914,899,1.11 [0.98-1.24],0.0977989470820542
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",22535,181,1.43 [1.12-1.82],0.0038039649814912
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",22618,403,0.98 [0.82-1.18],0.8482261329018517
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Oesophageal varices,20857,61,0.81 [0.49-1.33],0.403871547693811
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other aneurysm,21043,101,1.14 [0.80-1.62],0.4602146269768261
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other arrhythmias,17137,584,1.12 [0.96-1.29],0.150376671709715
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,21075,133,1.42 [1.07-1.89],0.0145267258048978
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,21264,322,0.97 [0.79-1.20],0.8054391485240173
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,16773,220,1.03 [0.80-1.31],0.8426258107001858
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other disorders of veins,20914,118,1.16 [0.83-1.61],0.3893201805143462
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,20841,45,1.11 [0.65-1.89],0.7061325723910836
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,20639,88,0.94 [0.63-1.40],0.7437370155344551
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,20970,174,1.02 [0.77-1.35],0.9150000657824052
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,17984,1431,0.99 [0.90-1.10],0.9066938099367337
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,20933,61,0.78 [0.47-1.28],0.3197355735805182
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,21655,713,1.01 [0.88-1.16],0.8859875279854665
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,21903,514,1.13 [0.97-1.33],0.1163459807825396
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",21508,957,1.01 [0.90-1.14],0.8464863803689083
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9103,411,0.96 [0.80-1.15],0.6510954349942646
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Peripheral artery disease,21488,578,1.06 [0.91-1.23],0.4427199530974477
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),21213,417,1.02 [0.85-1.22],0.840338964044431
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Pulmonary embolism,21975,586,1.08 [0.93-1.25],0.3266576191049578
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,22563,950,1.03 [0.91-1.15],0.6782860763526831
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Right bundle-branch block,17057,504,0.96 [0.82-1.14],0.6535361382172769
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Secondary right heart disease,21898,509,1.15 [0.98-1.34],0.0859587709434873
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,20812,261,1.02 [0.81-1.29],0.836568433382373
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22137,896,1.07 [0.95-1.21],0.2834632774152921
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22122,935,1.06 [0.95-1.20],0.303345236050193
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,21361,62,1.01 [0.64-1.60],0.9702862533554114
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,21046,104,0.89 [0.62-1.28],0.5370016571534656
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Transient ischemic attack,21691,319,1.04 [0.85-1.27],0.6960756218534079
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,21264,323,1.19 [0.98-1.45],0.077901321955849
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Varicose veins,21303,507,1.10 [0.94-1.29],0.2454430159556999
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,20961,121,0.83 [0.59-1.17],0.2867711301212589
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Venous thromboembolism,22386,926,1.03 [0.92-1.16],0.6027737868597663
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",22580,319,0.99 [0.81-1.22],0.943633249989108
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19350,1352,1.11 [1.00-1.22],0.0416995481839537
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Any mental disorder,22136,4138,1.06 [1.00-1.12],0.0422404492954328
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",22552,376,0.99 [0.82-1.20],0.9108621490606748
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19416,1418,1.15 [1.05-1.26],0.0035416383506373
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",18081,83,1.26 [0.87-1.84],0.2249592015199802
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Smoking dependency,22158,1154,1.14 [1.02-1.27],0.0239851932874653
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19413,1415,1.08 [0.98-1.20],0.0984356654477247
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Vascular dementia,21767,229,0.80 [0.62-1.03],0.0769884411951615
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Alzheimer disease,22659,584,1.03 [0.89-1.20],0.6907514622634491
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",13879,109,1.28 [0.92-1.78],0.1471901111705016
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Bell's palsy,20850,83,0.95 [0.64-1.43],0.820591557087901
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,21245,478,1.00 [0.85-1.19],0.9575363068592532
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Cerebral cysts,22225,245,1.05 [0.83-1.32],0.6992618071035712
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,22586,403,0.89 [0.74-1.07],0.2291882156289737
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,21816,73,1.09 [0.72-1.66],0.6814537244106398
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,22642,67,0.74 [0.46-1.19],0.215671981294639
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22064,84,1.25 [0.86-1.82],0.234947035584222
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Epilepsy,21181,298,0.91 [0.73-1.13],0.3740504022226444
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22205,1322,0.99 [0.90-1.10],0.9105550668151688
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,22605,914,0.97 [0.86-1.09],0.5949370791414891
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22012,3401,0.97 [0.91-1.03],0.3362240243985652
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Generalized epilepsy,22292,54,1.45 [0.93-2.25],0.1027437155348296
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Hemiplegia,22510,327,0.96 [0.78-1.17],0.6734350430498308
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Hydrocephalus,22056,76,1.17 [0.78-1.75],0.4383287388456451
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,22645,69,1.66 [1.16-2.37],0.0051486166145302
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,20833,66,0.68 [0.42-1.09],0.107116510011021
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,20837,70,1.27 [0.84-1.92],0.2594011772885644
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Memory loss,21519,141,0.89 [0.65-1.22],0.4554301718013449
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Migraine,21155,272,1.17 [0.95-1.45],0.143192988261707
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",22613,249,1.15 [0.92-1.43],0.2182437335926013
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Motor neuron disease,13961,168,0.97 [0.73-1.29],0.8115271802281112
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,22531,58,1.06 [0.66-1.70],0.8224884758946638
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",21960,1193,0.99 [0.89-1.10],0.8698704970375588
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Neurological diseases,21205,4275,1.00 [0.95-1.06],0.90619780301304
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,22066,323,0.89 [0.73-1.10],0.2946404184140712
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21183,416,1.06 [0.89-1.27],0.5010371197094987
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",22583,337,1.08 [0.88-1.31],0.4636867560621531
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,16949,964,1.02 [0.91-1.15],0.7503624636723537
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22064,84,1.07 [0.72-1.59],0.7360622661005312
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other disorders of nervous system,22140,160,0.86 [0.64-1.16],0.3142076680682862
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,21924,233,0.97 [0.77-1.24],0.8277571046244091
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other facial nerve disorders,20860,93,0.92 [0.63-1.36],0.6881309278169223
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other headache syndromes,20933,50,0.93 [0.55-1.57],0.7846133387667352
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other neurological diseases,22551,571,1.05 [0.90-1.22],0.5244456430649024
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other sleep disorders,21391,508,0.97 [0.82-1.15],0.7354938156139166
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Parkinson's disease,22626,677,0.96 [0.83-1.11],0.5608636471565167
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22025,45,1.06 [0.62-1.81],0.8229947164045044
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Restless leg syndrome,22659,109,0.99 [0.70-1.41],0.9664527764031028
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Sleep apnoea,22427,431,0.94 [0.78-1.12],0.4778106376688583
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Small fibre neuropathy,22303,57,0.90 [0.55-1.48],0.6824733329567669
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,22648,194,0.94 [0.72-1.23],0.6487568970422026
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,20833,66,0.84 [0.53-1.34],0.4717486421416029
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,22659,590,1.02 [0.88-1.19],0.7912833703196323
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),21708,223,0.79 [0.61-1.02],0.0710691129351744
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22029,151,0.97 [0.72-1.31],0.8584212843717968
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,22214,555,0.92 [0.78-1.07],0.2854035024902773
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,22407,262,0.88 [0.70-1.11],0.2888032884167227
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,21454,66,1.10 [0.71-1.70],0.6794645960887453
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,21427,39,1.25 [0.72-2.15],0.4286734956932937
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",22538,65,1.02 [0.65-1.60],0.9397094279585384
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,22348,221,0.92 [0.72-1.19],0.533756062292531
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2398,75,0.94 [0.61-1.46],0.7993837884336009
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2961,110,0.97 [0.68-1.39],0.8750171508855015
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,21980,102,1.23 [0.88-1.73],0.2274652613174431
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22367,1408,1.01 [0.91-1.11],0.8658553155924829
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",22254,866,1.03 [0.91-1.17],0.6402502417995017
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,21690,302,1.07 [0.87-1.32],0.4991250363420156
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",22586,927,1.00 [0.88-1.12],0.9471616442214053
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,22652,82,1.66 [1.19-2.31],0.0029497310705398
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,22515,856,0.95 [0.84-1.08],0.4588072532852058
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",22619,492,0.94 [0.80-1.12],0.5044883196719757
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,22541,221,1.15 [0.91-1.46],0.2504627047084383
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,21484,96,1.05 [0.73-1.53],0.7847270234194049
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,21487,99,1.04 [0.72-1.50],0.8274390490011263
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,21465,77,1.10 [0.73-1.65],0.6536887502395743
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,22529,989,1.00 [0.89-1.13],0.9642829538093438
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,21798,258,0.96 [0.76-1.20],0.701856248492946
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,21729,70,0.81 [0.51-1.28],0.3670289594970349
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,22247,120,0.85 [0.60-1.19],0.3435574729286806
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,22511,384,0.97 [0.81-1.17],0.7688910444321218
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,21873,214,1.02 [0.80-1.31],0.8796814237305088
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,22459,139,1.00 [0.73-1.36],0.976881038027291
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,22202,662,1.03 [0.89-1.19],0.6786929089779143
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22038,160,0.89 [0.66-1.20],0.4361804977516499
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20242,3158,1.04 [0.97-1.11],0.2744372409171895
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,22467,340,0.98 [0.81-1.20],0.8769140013881843
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,22646,184,1.15 [0.89-1.50],0.27848948705741
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,21913,525,1.00 [0.85-1.17],0.9958556912953472
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,22216,89,0.87 [0.58-1.30],0.4926766380111727
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,22643,73,1.74 [1.24-2.45],0.0014151968786613
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,21512,124,0.85 [0.61-1.20],0.360032432109361
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,21559,171,0.90 [0.68-1.20],0.4861282270792808
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,21122,163,1.44 [1.11-1.85],0.0056162423899502
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,21721,62,1.09 [0.70-1.72],0.6989848317370218
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",21028,69,0.67 [0.42-1.08],0.0977887271933919
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,21651,111,0.78 [0.54-1.12],0.1749305092896534
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",21826,286,1.05 [0.84-1.30],0.6782205388306275
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,21544,156,0.94 [0.70-1.27],0.700914364589269
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,21051,92,1.13 [0.78-1.64],0.5065495588764165
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,21087,128,1.18 [0.87-1.61],0.28242873463915
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,19772,2688,1.01 [0.94-1.08],0.8787973502269284
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,21480,92,1.25 [0.87-1.78],0.2308677187053803
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,22371,493,1.07 [0.91-1.26],0.3886345243883683
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,21953,75,1.44 [0.99-2.10],0.0581484493877116
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22080,202,1.24 [0.97-1.57],0.0862552855251462
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,22442,109,0.94 [0.66-1.34],0.7275098997456289
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,22611,137,0.99 [0.72-1.36],0.9621868643374654
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,22524,111,1.21 [0.87-1.68],0.2660224367733363
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,22394,61,0.80 [0.49-1.30],0.3709742564966648
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,22398,65,1.11 [0.72-1.72],0.63913323441573
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,22551,1216,1.03 [0.93-1.14],0.5634893283999016
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,22258,923,1.06 [0.94-1.20],0.3204632052382251
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,21484,149,0.72 [0.52-0.99],0.0408152799719262
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,21421,86,1.07 [0.72-1.57],0.7453391053337721
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute pharyngitis,22473,63,0.91 [0.57-1.45],0.6855788639736028
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,22587,177,0.94 [0.71-1.24],0.6421486244716488
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,22471,61,0.98 [0.61-1.57],0.9401756886438828
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,All influenza,20036,154,1.12 [0.84-1.49],0.4546435746444192
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),20033,151,1.15 [0.87-1.54],0.3312687891253561
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Allergic asthma (mode),13973,102,1.35 [0.97-1.88],0.0742746703778034
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Allergic rhinitis,22554,232,0.94 [0.74-1.20],0.6211402622538559
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15159,1671,1.04 [0.95-1.13],0.4440171079884927
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15520,1649,1.03 [0.94-1.13],0.4816281821548661
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),22155,174,1.18 [0.91-1.55],0.2123011858607094
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",19985,103,1.34 [0.96-1.86],0.0870136060839651
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Bronchiectasis,19014,506,1.19 [1.02-1.39],0.0292978713296689
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",18578,70,1.71 [1.20-2.44],0.0028556695537209
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21560,3052,1.07 [1.01-1.15],0.0316310509476563
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",21450,70,1.00 [0.65-1.55],0.9889150369171888
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic sinusitis,21513,133,1.32 [0.99-1.77],0.0582024264726762
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22375,1595,1.08 [0.99-1.18],0.0865634501136991
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Deviated nasal septum,21462,82,1.20 [0.82-1.76],0.3406016026641537
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20553,5981,1.06 [1.01-1.11],0.0120531865609074
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",21714,334,1.08 [0.89-1.31],0.4536932522032113
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Early onset COPD,20887,107,1.14 [0.82-1.60],0.4332653491059949
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Emphysema,18929,421,1.14 [0.96-1.35],0.1415746216982871
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21401,438,1.23 [1.04-1.45],0.0131517698510993
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22407,2525,1.08 [1.01-1.16],0.0301986800691824
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Interstitial lung disease,21442,479,1.28 [1.09-1.49],0.0019677498959479
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Later onset COPD,22152,1488,1.08 [0.98-1.18],0.1182671152728379
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,22643,482,1.08 [0.92-1.28],0.3364513933141512
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Nasal polyp,21474,94,1.24 [0.87-1.77],0.2324711923660819
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22378,1262,1.14 [1.03-1.26],0.0121855347187313
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of pleura,22376,2627,1.06 [0.99-1.14],0.0964964486772583
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22118,738,1.09 [0.96-1.25],0.1840978092179399
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other pleural conditions,19817,68,1.08 [0.70-1.66],0.7233671600411429
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,22542,573,1.25 [1.08-1.45],0.002299779330713
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22535,1680,1.11 [1.02-1.22],0.0148885458590864
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pleural effusion,21087,1338,1.02 [0.93-1.13],0.6267530619743753
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pleural plaque,19995,246,1.08 [0.86-1.36],0.4970029429654188
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22124,2242,1.08 [1.00-1.17],0.0458240475492902
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,22538,377,1.05 [0.87-1.26],0.6413816801137482
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pneumothorax,19912,163,0.75 [0.56-1.02],0.066428375500861
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pollen allergy,22648,197,1.09 [0.84-1.41],0.5067609746420045
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pulmonary oedema,22060,91,0.92 [0.62-1.37],0.6845433715336877
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Respiratory insufficiency,13940,69,1.62 [1.09-2.40],0.0179190260758063
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22356,1240,1.14 [1.03-1.26],0.0115402913302651
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,21614,234,0.94 [0.74-1.19],0.6020640602795659
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Viral pneumonia,20175,293,0.98 [0.79-1.22],0.8614356178150838
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",22164,236,0.96 [0.75-1.22],0.7258722624887992
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,7224,115,0.97 [0.69-1.38],0.8822223636996376
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,14349,61,1.26 [0.81-1.97],0.2996086145508865
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute appendicitis,22546,126,1.15 [0.84-1.58],0.3695096181094994
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute gastritis,15765,106,1.08 [0.76-1.52],0.6791513337278408
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute pancreatitis,20665,188,0.96 [0.73-1.26],0.7619688969758296
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute peritonitis,22179,108,1.19 [0.85-1.66],0.3194789485395907
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Alcoholic liver disease,21710,62,0.82 [0.50-1.34],0.4212265616435583
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Barrett oesophagus,16153,494,0.98 [0.83-1.16],0.8347234107159186
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",20619,142,1.24 [0.93-1.66],0.14786041164464
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",22249,142,1.24 [0.92-1.66],0.1560210476218209
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholecystitis,20689,212,1.15 [0.90-1.46],0.2733760071115997
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholelithiasis,21495,1018,1.11 [0.99-1.24],0.0763385792312353
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Chronic gastritis,15999,340,0.99 [0.82-1.21],0.9580728907353578
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Chronic pancreatitis,20530,53,0.76 [0.45-1.30],0.3191907086974994
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",22526,119,0.73 [0.51-1.05],0.0874782284981402
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Coeliac disease,20954,123,1.04 [0.75-1.43],0.8207677588289161
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Collagenous colitis,20952,102,0.90 [0.63-1.31],0.5910688404286375
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,22543,154,1.10 [0.82-1.47],0.5188094211727263
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Constipation,22382,2089,1.01 [0.93-1.09],0.8603801359536277
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn disease,20936,86,1.10 [0.75-1.62],0.630625959192331
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",22316,65,0.96 [0.61-1.52],0.8708499763240483
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn's disease NAS,20929,79,1.36 [0.94-1.98],0.1026050909304488
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Dental caries,22067,187,1.09 [0.84-1.42],0.5083195376238283
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,19592,2510,1.04 [0.97-1.12],0.2629308904780283
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of appendix,22576,156,1.04 [0.78-1.39],0.7669095111824569
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of liver,22540,892,1.05 [0.93-1.19],0.4191368579286784
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20149,4490,1.02 [0.96-1.07],0.5660282033115831
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",22340,460,1.02 [0.86-1.21],0.7884681271325005
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of peritoneum,22570,499,0.98 [0.83-1.15],0.7963087468468764
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,21972,92,0.83 [0.56-1.23],0.3572073128803443
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of salivary glands,21846,59,1.03 [0.64-1.65],0.9098990754346972
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22334,1503,0.99 [0.90-1.09],0.8727335182480139
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of tongue,21862,92,0.85 [0.57-1.26],0.4113843126910913
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",21952,1475,1.10 [1.00-1.21],0.0428694451312491
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17984,3696,0.99 [0.94-1.06],0.8343101958632534
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Duodenal ulcer,15903,244,1.12 [0.90-1.41],0.3113585242768709
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",22565,198,1.04 [0.80-1.34],0.7894508803404127
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,22623,26,1.27 [0.65-2.49],0.4806668204246433
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,21788,140,0.84 [0.61-1.16],0.2911568870472037
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14395,107,1.34 [0.96-1.86],0.0852362837972306
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Functional dyspepsia,16211,552,0.99 [0.85-1.15],0.8724800369514861
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastric ulcer,16081,422,1.08 [0.91-1.29],0.3683424947008045
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18261,2602,0.99 [0.93-1.07],0.8610665584908677
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,16302,643,1.09 [0.95-1.26],0.2202520598181805
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16356,8043,1.03 [0.99-1.07],0.147537434122245
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,GI-bleeding,22084,1253,0.99 [0.90-1.10],0.912615063454162
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,21925,45,0.75 [0.42-1.33],0.323965158827089
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,15264,1165,0.97 [0.87-1.08],0.5850307268278825
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",21714,66,0.78 [0.49-1.26],0.3126688377161578
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Hernia,20649,3567,1.04 [0.98-1.10],0.2210387005560716
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Impacted teeth,22627,24,1.54 [0.80-2.94],0.1931003831130277
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Impaction of intestines,14365,77,1.32 [0.89-1.94],0.1639283144602571
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Inguinal hernia,18156,1074,1.03 [0.92-1.15],0.5957654755714454
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",17203,121,1.04 [0.74-1.44],0.8374376437099076
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,14403,115,0.85 [0.60-1.21],0.3632341311346208
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal malabsorption,20970,139,0.95 [0.69-1.29],0.7224037925999878
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14789,501,0.97 [0.82-1.14],0.7110942492822981
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,22626,329,1.02 [0.84-1.25],0.820382103774378
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,21623,773,1.19 [1.05-1.35],0.0056646342676661
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,21919,1069,1.12 [1.00-1.25],0.0412886402808001
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15871,212,0.97 [0.75-1.25],0.8144618434576462
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophagitis,16341,682,0.99 [0.86-1.13],0.8494518197901686
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,22605,133,1.22 [0.90-1.64],0.2008308976733045
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,17169,87,0.94 [0.63-1.39],0.7457990859417609
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15645,1357,1.05 [0.96-1.16],0.2863747735845828
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,20831,354,1.11 [0.91-1.34],0.297689493024961
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,20619,142,1.29 [0.97-1.72],0.0789668655917917
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestine,16178,1890,1.00 [0.92-1.09],0.9439085802726576
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestines,20385,6097,1.00 [0.95-1.05],0.9237508485213616
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,21826,208,1.15 [0.90-1.46],0.2725096497730752
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of liver,22384,736,1.02 [0.89-1.16],0.804178022093499
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,16407,748,1.02 [0.90-1.17],0.7496223198412695
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of pancreas,20688,211,1.07 [0.84-1.38],0.573026225308318
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,22494,423,0.94 [0.79-1.12],0.4951922797755222
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,16732,1073,0.99 [0.89-1.11],0.8982401860715918
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22100,1269,0.99 [0.90-1.10],0.9176894121051662
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22051,171,1.00 [0.76-1.32],0.9931024712722984
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16423,2135,1.01 [0.93-1.09],0.8456048503324709
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),17788,2129,1.02 [0.95-1.11],0.5817473559208718
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,21758,110,0.92 [0.65-1.32],0.6532248749829295
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,21796,946,1.13 [1.01-1.27],0.0369491396764498
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14725,437,0.98 [0.83-1.18],0.8660182335716564
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,22619,29,1.25 [0.66-2.37],0.4851548179171403
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14896,608,0.95 [0.81-1.10],0.4673651442257508
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",20982,151,0.92 [0.68-1.25],0.6095606690654971
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Recurring oral aphthae,22647,52,0.81 [0.48-1.38],0.4334527455121095
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,21872,99,1.12 [0.79-1.60],0.5219756597211183
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Toxic colitis,20926,76,0.85 [0.56-1.32],0.4773318027771193
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15991,332,0.96 [0.78-1.17],0.6603578758472735
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcerative colitis,21013,163,0.96 [0.72-1.28],0.7772408410271973
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",20979,129,0.87 [0.62-1.21],0.4034440722850562
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Umbilical hernia,17329,247,0.97 [0.76-1.22],0.7754930107877793
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14529,241,0.90 [0.70-1.14],0.3791621919576584
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ventral hernia,17359,277,0.97 [0.78-1.21],0.7864892224844144
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Volvulus,14383,95,0.76 [0.51-1.13],0.1683746866552214
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,22555,417,1.06 [0.88-1.26],0.5497379225771892
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,22306,63,1.47 [0.98-2.21],0.0618655356087572
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,20147,162,1.06 [0.80-1.41],0.6754716655326826
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22035,804,1.00 [0.88-1.14],0.9987124879745044
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",21372,141,1.22 [0.91-1.63],0.1786977416081189
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,20603,618,1.00 [0.87-1.16],0.9662579345119888
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,22322,312,1.30 [1.07-1.58],0.007138801425772
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,22559,549,1.20 [1.03-1.39],0.0164686864167148
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22057,47,1.37 [0.84-2.23],0.2038056258230293
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21083,3657,1.01 [0.95-1.07],0.83103669287217
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,22231,427,0.94 [0.79-1.13],0.5190955377155858
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22104,300,0.97 [0.79-1.20],0.796612445702105
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22277,1046,1.00 [0.89-1.12],0.9942418369991244
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",22640,59,0.89 [0.55-1.45],0.6404468804268844
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,20041,56,0.78 [0.46-1.30],0.3338035686718176
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,21863,59,1.02 [0.64-1.64],0.9298326390366524
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,22309,299,1.30 [1.07-1.58],0.0093615287725897
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,20579,594,0.96 [0.82-1.11],0.5747930826613488
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,20075,90,0.95 [0.64-1.40],0.7941275292291332
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,22571,96,0.90 [0.61-1.32],0.5744585393159591
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,21463,232,1.11 [0.88-1.40],0.3920658273593239
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,22461,218,0.91 [0.71-1.17],0.4772554417313588
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22103,93,1.19 [0.83-1.71],0.3426325136560562
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,20062,77,1.30 [0.89-1.91],0.1781494004853148
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22054,2069,1.02 [0.94-1.11],0.6106226223913636
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",20619,634,0.95 [0.82-1.09],0.4550696335400179
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,20078,93,0.89 [0.61-1.32],0.5661538535970196
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,22572,329,0.99 [0.81-1.22],0.9500816026758784
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,22082,72,1.05 [0.69-1.61],0.8131851946869214
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,22512,269,1.01 [0.81-1.26],0.9402161144291772
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,22587,449,1.02 [0.86-1.20],0.8612207002653258
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,20105,120,1.11 [0.81-1.54],0.5115000052776184
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,20318,333,0.81 [0.66-1.00],0.0458822225451967
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,22575,437,1.03 [0.87-1.23],0.7213866692217126
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",20313,328,1.24 [1.02-1.50],0.0283075797979218
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,22630,155,0.98 [0.73-1.32],0.8868828023686134
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,18860,77,0.93 [0.61-1.41],0.7213986423786474
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,19975,6310,1.02 [0.97-1.07],0.3877553372482729
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18586,4921,1.00 [0.95-1.06],0.9022861195970284
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,18832,49,0.99 [0.59-1.68],0.974647576869558
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,18789,144,1.04 [0.76-1.40],0.8229008812918771
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,18834,189,0.83 [0.63-1.09],0.1871398791883463
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,22400,65,1.55 [1.05-2.29],0.0287419708027236
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",18792,147,0.97 [0.72-1.32],0.8623151196998128
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,15127,1462,1.01 [0.92-1.11],0.7720417676877409
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",22452,244,1.12 [0.89-1.40],0.332279032338992
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,19222,577,1.09 [0.94-1.26],0.2483102948035644
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18337,7873,1.02 [0.98-1.06],0.303606811243133
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20160,116,0.92 [0.65-1.30],0.6445751222055556
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,18965,182,0.99 [0.75-1.30],0.928671114420142
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,19280,497,1.08 [0.92-1.27],0.3395972298298639
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21737,3092,1.02 [0.96-1.09],0.4942155938965912
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,19089,306,0.77 [0.62-0.96],0.0188327670540423
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,18929,146,1.17 [0.88-1.56],0.285917277527959
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,18894,111,1.25 [0.90-1.72],0.1824093978803644
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,21930,95,1.03 [0.71-1.49],0.8724935368730863
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15627,1962,0.96 [0.89-1.05],0.3832852966654891
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14438,773,1.13 [1.00-1.28],0.0597941108012262
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22567,767,1.13 [0.99-1.29],0.0596691712993435
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,13740,75,1.33 [0.91-1.95],0.1366706842036754
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),13966,301,1.08 [0.88-1.33],0.4421386568878406
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,19046,263,0.96 [0.76-1.20],0.6969209481918406
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14137,472,1.03 [0.88-1.22],0.6884978797084473
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,18725,80,1.56 [1.11-2.19],0.0108829843172562
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,19319,674,1.05 [0.91-1.20],0.5176682666527403
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,18956,311,1.07 [0.87-1.31],0.5086745342456295
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14107,442,1.03 [0.87-1.22],0.7541732993369169
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,18854,71,1.10 [0.72-1.68],0.6653226187539041
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",18843,60,0.94 [0.58-1.51],0.797285782877087
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20126,82,0.92 [0.61-1.39],0.6933220386658203
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22233,2189,0.95 [0.88-1.03],0.2357844253318385
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21583,1539,0.94 [0.86-1.03],0.1929155964574146
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",22487,533,1.21 [1.05-1.41],0.0111204678276289
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16730,3065,1.04 [0.97-1.11],0.2646366482405162
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,13707,42,1.00 [0.57-1.75],0.99649934022287
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,18885,102,1.20 [0.85-1.69],0.3082128911155742
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,13734,69,0.89 [0.57-1.39],0.6139454139461241
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),13800,135,1.08 [0.80-1.46],0.6225495125950394
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,20285,241,1.07 [0.85-1.35],0.5511865978543342
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,20547,503,0.96 [0.82-1.14],0.6604268923022858
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,22635,111,1.37 [1.00-1.87],0.0516339262294408
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",20597,1952,1.00 [0.92-1.08],0.9144971179342222
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,18859,76,1.37 [0.94-2.00],0.1022522079254599
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),13816,151,0.94 [0.70-1.27],0.7021173103629109
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,19423,778,1.02 [0.89-1.16],0.781102245382954
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15806,2141,1.05 [0.97-1.14],0.1979926251003916
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,21955,120,1.09 [0.79-1.51],0.6080861722808344
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,22647,60,1.58 [1.06-2.35],0.0259914390126884
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,18860,77,0.88 [0.57-1.35],0.5520051606220362
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20115,1332,1.10 [1.00-1.22],0.0508209270320645
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,18890,107,1.03 [0.72-1.46],0.8755971429461396
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15705,2040,1.07 [0.99-1.15],0.1129507276609955
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,20163,119,0.98 [0.70-1.37],0.9107728298925408
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,18819,36,1.03 [0.57-1.87],0.926701906779504
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,18832,187,0.85 [0.65-1.12],0.2562281627616709
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,19460,677,1.04 [0.91-1.20],0.5385430656590967
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22313,478,1.10 [0.93-1.29],0.2671757006437966
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,19299,654,1.00 [0.86-1.15],0.9622710922807448
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,22502,528,1.20 [1.03-1.39],0.0192608733125309
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,22632,69,1.77 [1.24-2.52],0.0016435101508303
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,18949,166,0.92 [0.69-1.23],0.57463461684064
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17623,871,1.06 [0.93-1.20],0.3759377034234991
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,19417,634,1.10 [0.96-1.27],0.1792083120530023
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19059,276,0.78 [0.62-0.99],0.0380464476315162
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",13734,69,1.13 [0.75-1.72],0.557866107935768
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16731,3066,1.09 [1.02-1.16],0.0071493096785054
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14490,825,1.09 [0.97-1.24],0.1481628293536857
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22205,370,1.08 [0.90-1.30],0.4171748043382194
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",22604,80,1.19 [0.80-1.75],0.3911465622659149
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",20059,70,0.97 [0.62-1.51],0.8903073059502659
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,13726,61,1.54 [1.03-2.29],0.0338925126491391
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,18754,109,1.15 [0.82-1.61],0.4090413828477931
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14205,540,1.23 [1.07-1.43],0.0049276413400725
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,19112,329,1.02 [0.83-1.24],0.8808046735171329
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,18925,280,1.20 [0.97-1.47],0.0906834222391946
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,18909,264,0.98 [0.78-1.23],0.8707819491651335
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,15927,67,1.17 [0.76-1.79],0.4722272567233609
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",22637,74,1.65 [1.16-2.36],0.0054610312102684
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,19325,542,0.99 [0.85-1.16],0.9189013429651304
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],21924,89,1.18 [0.82-1.71],0.3730866011656334
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21384,2601,1.03 [0.96-1.10],0.4471258889674655
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",18932,149,0.89 [0.66-1.21],0.4626982531558332
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,19352,707,1.08 [0.94-1.24],0.2678360957058486
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21326,263,0.88 [0.70-1.11],0.2705459243715022
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,18895,250,1.19 [0.95-1.48],0.1218157832233844
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20618,1973,1.03 [0.95-1.12],0.4564840214258322
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,19936,1291,1.04 [0.94-1.16],0.3962307051081215
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],18842,59,1.19 [0.75-1.88],0.459178262793295
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,21949,114,1.01 [0.72-1.42],0.946860461645862
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,18943,160,1.12 [0.85-1.48],0.4275701997163409
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,18875,92,0.98 [0.67-1.44],0.9379111740600058
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),13741,76,1.19 [0.80-1.77],0.3779762326511258
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Acute renal failure,21186,2212,1.12 [1.04-1.21],0.0029909678866068
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9058,24,1.44 [0.76-2.74],0.2615211719148646
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,11499,34,1.21 [0.68-2.15],0.513725688176909
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,22334,295,1.11 [0.90-1.36],0.3465330575905411
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,22138,99,1.02 [0.71-1.48],0.9045323564788028
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21251,2277,1.10 [1.02-1.19],0.0147610963684494
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,22430,130,1.69 [1.29-2.21],0.0001223641971302
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,22353,398,1.01 [0.84-1.21],0.9094755572750484
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Cystitis,18893,297,0.97 [0.78-1.20],0.745980214943126
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Dialysis,19068,94,1.42 [1.00-2.02],0.0471986819219534
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9987,2089,1.04 [0.96-1.13],0.3283938338798566
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Disorders of breast,11599,134,1.38 [1.04-1.83],0.0246049220382201
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Endometriosis,9071,37,1.28 [0.74-2.20],0.3788142699920452
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9609,575,0.97 [0.83-1.12],0.661224745388092
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18656,6150,1.04 [0.99-1.09],0.1331561228689007
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,22396,96,1.25 [0.87-1.78],0.2256606174725319
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hydrocele,8010,112,0.97 [0.68-1.38],0.856021309074393
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,19039,340,1.04 [0.85-1.27],0.7117209886330294
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9676,1778,1.02 [0.94-1.12],0.590748472804951
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,11665,156,0.85 [0.63-1.14],0.2777859388428333
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),8023,125,0.82 [0.58-1.15],0.2500876539010764
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,18682,86,0.96 [0.64-1.43],0.8275626128482114
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10051,1017,0.92 [0.82-1.03],0.1337905797708172
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,7959,61,0.86 [0.53-1.41],0.5596928595419395
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9072,38,0.67 [0.36-1.27],0.2194336090907712
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",22645,86,0.96 [0.65-1.43],0.8410528168565152
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",22647,80,0.70 [0.45-1.08],0.1072328754409922
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21488,2892,1.02 [0.95-1.09],0.5852741078023183
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,19510,914,1.01 [0.89-1.14],0.8789836622013301
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,11516,51,1.29 [0.80-2.06],0.2944562410203234
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22574,619,1.05 [0.91-1.21],0.5162033766202885
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,8048,150,1.13 [0.84-1.52],0.4164231617700547
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,8057,159,1.17 [0.88-1.55],0.2828754416467002
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,8043,145,0.88 [0.64-1.21],0.4232581246181235
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,22618,84,1.00 [0.68-1.49],0.9848196524656072
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,20899,2303,1.06 [0.98-1.14],0.1620172968669027
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,11589,80,0.85 [0.56-1.29],0.4397784781491292
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9103,69,1.18 [0.78-1.78],0.4335623765550275
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9174,140,0.92 [0.68-1.26],0.6050312031427647
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9083,49,1.02 [0.61-1.71],0.9357405201785232
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9133,99,0.98 [0.68-1.41],0.9225331448080754
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,19101,402,1.11 [0.93-1.33],0.2471203987801143
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,22154,199,1.07 [0.83-1.38],0.5895700114341611
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9157,123,1.02 [0.74-1.41],0.8904843513231374
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9059,25,0.81 [0.38-1.72],0.5805065863491288
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9242,208,0.84 [0.65-1.09],0.1930443791807129
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9124,90,1.11 [0.77-1.60],0.5837083460863391
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9236,202,0.89 [0.68-1.15],0.3745411146711228
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,22348,48,0.80 [0.46-1.40],0.4394640896296902
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",8051,153,1.00 [0.74-1.35],0.9771779293359084
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22371,3672,1.10 [1.03-1.17],0.0020946853697242
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",18790,91,1.15 [0.80-1.67],0.4522818680297863
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,19151,177,1.02 [0.77-1.34],0.9158918862386786
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,22074,35,1.09 [0.59-2.01],0.7751193749335034
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urethral stricture,18857,261,1.03 [0.83-1.30],0.7693068895463224
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urolithiasis,22415,376,1.10 [0.92-1.33],0.3015220633582373
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9069,35,0.87 [0.46-1.65],0.6635688592844224
